# Dobutamine Stress Echocardiography in LF/LG Aortic Stenosis and Wild-type Transthyretin Amyloid Cardiomyopathy

> **NCT06372301** · NA · UNKNOWN · sponsor: **Steen Hvitfeldt Poulsen** · enrollment: 24 (estimated)

## Conditions studied

- Transthyretin Amyloid Cardiomyopathy
- Aortic Stenosis

## Interventions

- **DIAGNOSTIC_TEST:** Dobutamine stress echocardiography

## Key facts

- **NCT ID:** NCT06372301
- **Lead sponsor:** Steen Hvitfeldt Poulsen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04-02
- **Primary completion:** 2025-11-01
- **Final completion:** 2026-04-01
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2024-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06372301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06372301, "Dobutamine Stress Echocardiography in LF/LG Aortic Stenosis and Wild-type Transthyretin Amyloid Cardiomyopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06372301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*